Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 29562156

Venetoclax-Rituximab in Relapsed or Refractory Chronic Lymphocytic Leukemia.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
N Engl J Med
Publication date
2018 Mar 22
First author
Seymour JF

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Nat Rev Clin Oncol. 2018 Jun;15(6):344-345. doi: 10.1038/s41571-018-0017-z.
    note
    Source null
    related pmid
    29651129
    relationship
    Comment in
  2. citation
    N Engl J Med. 2018 May 31;378(22):2141-2. doi: 10.1056/NEJMc1805135.
    note
    Source null
    related pmid
    29847897
    relationship
    Comment in
  3. citation
    N Engl J Med. 2018 May 31;378(22):2142-3. doi: 10.1056/NEJMc1805135.
    note
    Source null
    related pmid
    29847898
    relationship
    Comment in

Authors and identifiers

  1. name
    Seymour JF
    type
    Author
  2. name
    Kipps TJ
    type
    Author
  3. name
    Eichhorst B
    type
    Author
  4. name
    Hillmen P
    type
    Author
  5. name
    D'Rozario J
    type
    Author
  6. name
    Assouline S
    type
    Author
  7. name
    Owen C
    type
    Author
  8. name
    Gerecitano J
    type
    Author
  9. name
    Robak T
    type
    Author
  10. name
    De la Serna J
    type
    Author
  11. name
    Jaeger U
    type
    Author
  12. name
    Cartron G
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Seymour JF
    type
    Author
  2. name
    Kipps TJ
    type
    Author
  3. name
    Eichhorst B
    type
    Author
  4. name
    Hillmen P
    type
    Author
  5. name
    D'Rozario J
    type
    Author
  6. name
    Assouline S
    type
    Author
  7. name
    Owen C
    type
    Author
  8. name
    Gerecitano J
    type
    Author
  9. name
    Robak T
    type
    Author
  10. name
    De la Serna J
    type
    Author
  11. name
    Jaeger U
    type
    Author
  12. name
    Cartron G
    type
    Author
bibliography ids
  1. nci-bib-9dd3b1cb33cd680ad3e2e47c
book metadata
content sha256
4f974a586686f234dbbedb2705bccd6b00c369b83da6c8dd841a77c9c5fb2eb8
document type
citation
dois
  1. 10.1056/NEJMoa1713976
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:29562156
immutable id
pubmed:29562156@4f974a586686f234dbbedb2705bccd6b00c369b83da6c8dd841a77c9c5fb2eb8
journal
abbreviation
N Engl J Med
issn electronic
1533-4406
issn print
0028-4793
issue
12
name
The New England journal of medicine
nlm unique id
0255562
pages
1107-1120
volume
378
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Nat Rev Clin Oncol. 2018 Jun;15(6):344-345. doi: 10.1038/s41571-018-0017-z.
    note
    Source null
    related pmid
    29651129
    relationship
    Comment in
  2. citation
    N Engl J Med. 2018 May 31;378(22):2141-2. doi: 10.1056/NEJMc1805135.
    note
    Source null
    related pmid
    29847897
    relationship
    Comment in
  3. citation
    N Engl J Med. 2018 May 31;378(22):2142-3. doi: 10.1056/NEJMc1805135.
    note
    Source null
    related pmid
    29847898
    relationship
    Comment in
outcomes validated
false
pmid
29562156
provenance
batch id
ec9444d0f4cade22eb9f
provider
NCBI PubMed ESummary
record sha256
effa34a8800f171401510260260a727d0ed5ab0705c35c80d9dbfc8929f1e438
response sha256
6eef0d8cc09b77e73af656f6390cc734befb84fbc4c229b886e81e5d95bece31
retrieved at
2026-09-09T23:47:30.975610+00:00
publication date
display
2018 Mar 22
precision
day
year
2018
publication types
  1. Clinical Trial, Phase III
  2. Journal Article
  3. Multicenter Study
  4. Randomized Controlled Trial
  5. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/29562156/
title
Venetoclax-Rituximab in Relapsed or Refractory Chronic Lymphocytic Leukemia.

Preserved source evidence · Not medical advice